TSS
BIS icon

Two Sigma Securities’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Two Sigma Securities’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,036
Closed -$320K – 274
2015
Q3 		$320K Buy
+1,036
New +$244K 0.5% 67

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAM
Chesapeake Asset Management New York $126M AUM 36.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Two Sigma Securities's BIS Position: Q4 2015 in Review

Two Sigma Securities sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2015, closing a stake of 1,036 shares — an estimated $320K sold.

Two Sigma Securities first reported a position in BIS in Q3 2015 and held it in 1 quarter. The position peaked at $320K in Q3 2015. 15 funds tracked by Wall St. Rank hold BIS as of Q4 2015.

  • Two Sigma Securities reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2015 after selling out during the quarter.
  • Two Sigma Securities sold 1,036 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2015, an estimated $320K.
  • Two Sigma Securities first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q3 2015 and held it in 1 quarter.
  • Two Sigma Securities's ProShares UltraShort NASDAQ Biotechnology position peaked at $320K in Q3 2015.
  • 15 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2015.

Based on Two Sigma Securities's 13F filing for Q4 2015, filed 16 Feb 2016.